- Home
- DGII vs QURE Comparison
DGII vs QURE Comparison
Compare DGII & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DGII | QURE |
|---|---|---|
| Founded | 1985 | 1998 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | DGII | QURE |
|---|---|---|
| Price | $43.00 | $22.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 12 |
| Target Price | $48.80 | ★ $58.55 |
| AVG Volume (30 Days) | 300.2K | ★ 2.3M |
| Earning Date | 02-04-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 77.05 | N/A |
| EPS | ★ 1.08 | N/A |
| Revenue | ★ $430,221,000.00 | $15,751,000.00 |
| Revenue This Year | $10.51 | N/A |
| Revenue Next Year | $8.01 | $153.45 |
| P/E Ratio | $39.67 | ★ N/A |
| Revenue Growth | ★ 1.46 | N/A |
| 52 Week Low | $22.39 | $7.76 |
| 52 Week High | $48.00 | $71.50 |
Technical Indicators
Market Signals| Indicator | DGII | QURE |
|---|---|---|
| Relative Strength Index (RSI) | 44.94 | 40.57 |
| Support Level | $42.48 | $22.11 |
| Resistance Level | $45.13 | $24.43 |
| Average True Range (ATR) | 1.21 | 1.36 |
| MACD | -0.39 | 0.42 |
| Stochastic Oscillator | 5.54 | 18.68 |
Price Performance
Historical ComparisonAbout DGII Digi International Inc.
Digi International Inc is a Minnesota corporation that provides business and mission-critical Internet of Things (IoT) connectivity products and services. It operates through two segments: IoT Products & Services, which supports OEMs, enterprise, and government customers in deploying secure IoT connectivity solutions, and IoT Solutions, consisting of SmartSense and its Managed Network-as-a-Service (MNaaS) business offering wireless temperature and condition-based monitoring, employee task management, label printing, and other services. The company generates the majority of its revenue from the IoT Products & Services segment and mainly from the United States, with a presence in Europe, the Middle East and Africa, and the Rest of the world.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.